SEARCH
Subscribe
Track all markets on TradingView

3 Canadian Healthcare Stocks Thriving in a Down Market

Published:

Reading time: 4 min.

The Canadian healthcare stocks on our list have surged 177% on average over the past three months while the TSX has slumped

SmallCapPower | April 4, 2018: The Canadian healthcare sector is struggling, with the S&P/TSX Capped Healthcare Index declining 14% over the past three months while the Dow Jones Healthcare Index decreased 4%. In contrast, the TSX is down 8% while the Dow Jones has eased 5%. However, the Canadian healthcare stocks on our list today have seen strong returns despite poor sector performance, and could continue to rise, especially if the sector recovers.

Biocure Technology Inc. (CSE:CURE) – $1.14
Pharmaceuticals

Biocure Technology is a U.S.-based pharmaceutical company. The Company’s primary product is its in-situ polymerizing hydrogels, used in dressings, tissue adhesives, and other applications. Biocure also offers block copolymers, designed to mimic biological cell membranes.

  • Market Cap: $49.5 Million
  • 1 Month Total Return: 15.2%
  • 3 Month Total Return: 250.8%

Antibe Therapeutics Inc. (TSXV:ATE) – $0.46
Biotechnology & Medical Research

Antibe Therapeutics is a Canada-based biotech company with several products in development. The Company’s drug division produces ATB-346, a Non-Steroidal Anti-Inflammatory Drug (NSAID), with minimal GI damage and effect on blood pressure. Its Citagenix subsidiary produces dental regenerative medicine for oral surgery.

  • Market Cap: $80.4 Million
  • 1 Month Total Return: 75.0%
  • 3 Month Total Return: 160.0%
  • 52 Week Total Return: 127.5%

ProMIS Neurosciences Inc. (TSX:PMN) – $0.46
Biotechnology & Medical Research

ProMIS is a Canada-based biotech company focused on treating neurodegenerative diseases. The Company has seven products in development, four of which target Alzheimer’s, two which target ALS, and one which targets Parkinson’s. ProMIS aims to treat misfolded proteins, using a molecular target identification system licensed from UBC.

  • Market Cap: $104.1 Million
  • 1 Month Total Return: 27.8%
  • 3 Month Total Return: 119.0%

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below:

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
test28872674
test28872674

Related articles

Recent articles

© SmallCapPower 2024